Ayala Pharmaceuticals Inc (ADXS)

[Chemist823]

This company really isn't very good at public/ shareholder relations. I've seen companies that do so much better, disappointing. Makes them an easier target. Doesn't change the data or the eventual approvals but can force dilution on less than ideal terms, lower buy out price, etc. May not have done much good for them to be out there making noise, getting interviews, doing presentations but we'll never know because they seem to go silent there for a long period while the stock languished.